Department of Pharmacology, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California, San Diego, La Jolla, CA 92093;
Department of Pharmacology, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California, San Diego, La Jolla, CA 92093;Department of Structural Biology, Weizmann Institute of Science, Rehovot 76100, Israel;
Proc Natl Acad Sci U S A. 2014 Jul 22;111(29):10749-54. doi: 10.1073/pnas.1410992111. Epub 2014 Jul 8.
The nicotinic acetylcholine receptor (nAChR) and the acetylcholine binding protein (AChBP) are pentameric oligomers in which binding sites for nicotinic agonists and competitive antagonists are found at selected subunit interfaces. The nAChR spontaneously exists in multiple conformations associated with its activation and desensitization steps, and conformations are selectively stabilized by binding of agonists and antagonists. In the nAChR, agonist binding and the associated conformational changes accompanying activation and desensitization are cooperative. AChBP, which lacks the transmembrane spanning and cytoplasmic domains, serves as a homology model of the extracellular domain of the nAChRs. We identified unique cooperative binding behavior of a number of 4,6-disubstituted 2-aminopyrimidines to Lymnaea AChBP, with different molecular variants exhibiting positive, nH > 1.0, and negative cooperativity, nH < 1.0. Therefore, for a distinctive set of ligands, the extracellular domain of a nAChR surrogate suffices to accommodate cooperative interactions. X-ray crystal structures of AChBP complexes with examples of each allowed the identification of structural features in the ligands that confer differences in cooperative behavior. Both sets of molecules bind at the agonist-antagonist site, as expected from their competition with epibatidine. An analysis of AChBP quaternary structure shows that cooperative ligand binding is associated with a blooming or flare conformation, a structural change not observed with the classical, noncooperative, nicotinic ligands. Positively and negatively cooperative ligands exhibited unique features in the detailed binding determinants and poses of the complexes.
烟碱型乙酰胆碱受体(nAChR)和乙酰胆碱结合蛋白(AChBP)是五聚体寡聚体,其中烟碱激动剂和竞争性拮抗剂的结合位点位于选定的亚基界面上。nAChR 自发存在于与其激活和脱敏步骤相关的多种构象中,并且构象通过激动剂和拮抗剂的结合而选择性稳定。在 nAChR 中,激动剂结合及其伴随的激活和脱敏过程中的构象变化是协同的。缺乏跨膜和细胞质结构域的 AChBP 作为 nAChR 细胞外结构域的同源模型。我们确定了一些 4,6-取代的 2-氨基嘧啶对林蛙 AChBP 的独特协同结合行为,不同的分子变体表现出正协同性,nH > 1.0,和负协同性,nH < 1.0。因此,对于一组独特的配体,nAChR 替代物的细胞外结构域足以容纳协同相互作用。AChBP 与每个配体复合物的 X 射线晶体结构允许鉴定配体中赋予协同行为差异的结构特征。两组分子都结合在激动剂 - 拮抗剂位点,这与它们与 epibatidine 的竞争一致。AChBP 四级结构的分析表明,协同配体结合与绽放或闪耀构象相关,与经典的非协同性烟碱配体不同,未观察到这种结构变化。正协同和负协同配体在复合物的详细结合决定因素和构象中表现出独特的特征。